Concepedia

Ajita Singh

AS

Statistics

Publications

17

Citations

2.1K

H-Index

16

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Banaras Hindu University

Institute of Medical Sciences

VA Boston Healthcare System

Ajita Singh is an author at Dana-Farber Cancer Institute specializing in pharmacology, oncology, and apoptosis.

Publications per year

2001–2022

17

Publications

17

Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo

Ajita Singh · Carcinogenesis · 2003 · 357 citations

Medicine, Oncology, Pharmacology +17

Sulforaphane-induced G2/M Phase Cell Cycle Arrest Involves Checkpoint Kinase 2-mediated Phosphorylation of Cell Division Cycle 25C

Shivendra V. Singh, Anna Herman-Antosiewicz, Ajita Singh et al. · Journal of Biological Chemistry · 2004 · 347 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

Dharminder Chauhan, Ajita Singh, Mohan Brahmandam et al. · Cancer Cell · 2009 · 297 citations · Full text

Life Sciences, Cell Biology, Immunology +17

A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma

Dharminder Chauhan, Ajita Singh, Monette Aujay et al. · Blood · 2010 · 217 citations · Full text

Medicine, Oncology, Pharmacology +11

Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma

Dharminder Chauhan, Ajita Singh, Mohan Brahmandam et al. · Blood · 2007 · 190 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 17